Cigna Healthcare (Commercial) · facet joint interventions
✓ conditional · commercial
Criteria checklist
0 of 6 ticked- enumerated: yes
- covered:
- name: Axial facet-mediated pain (C2-3 to L5-S1)
- criteria:
- pain pattern: axial, without untreated radiculopathy (exception: facet synovial cyst with concordant radiculopathy)
- chronic pain min months: 3
- conservative min weeks: 4
- segment not fused: yes
- investigational:
- therapeutic facet injections (NMN except when RFA is contraindicated)
- cooled RF, pulsed RF, cryo, chemical, laser, endoscopic rhizotomy
- ultrasound-guided injection
- basivertebral and SI-joint RF (experimental/investigational)
- required: yes
- min duration months: not stated in the policy
- min duration weeks: 4
- satisfied by:
- failed >=4 weeks conservative (exercise/PT/chiro/NSAIDs)
- contraindicated
- modalities named:
- exercise / physical therapy
- chiropractic
- NSAIDs
- required: no
- min duration days: not stated in the policy
- success criteria: not stated in the policy
- threshold is binding: no
- required: no
- must clear: no
- note posture: not required
- required before: radiofrequency neurotomy (CMM-208)
- count: 2
- relief threshold pct: 80
- rfa intent: diagnostic blocks covered only if RFA is being considered
- applies: yes
- diagnostic blocks per level: 2
- levels: <=3 contiguous (<=6 if bilateral)
- rfa sessions per level per 12mo: 2
- rfa spacing: >=6 months apart
- repeat rfa requires: >=50% relief lasting >=12 weeks
- waveform: conventional thermal RF only
Cigna delegates facet diagnostics to eviCore CMM-201 and RFA to CMM-208. Dual MBB/IA blocks each >=80% (matches Medicare) gate RFA, and diagnostics are covered only with RFA intent. STRICTER than Medicare on technology: Cigna covers CONVENTIONAL THERMAL RF only — cooled RF, pulsed RF, cryo, chemical, laser, and endoscopic rhizotomy are not covered (Medicare permits cooled RF); standalone therapeutic facet injections are NMN except when RFA is contraindicated. Repeat RFA needs >=50% relief lasting >=12 weeks. From the actual fetched eviCore PDFs. PENDING: 2026-08-04 successor versions.
Ticks are a documentation aid — nothing is stored; they reset on reload.
Dot phrase
Lean narrative A&P attestation. `***` = fill-in. Fully self-contained — rendered from eviCore CMM-201 (blocks) + CMM-208 (RFA), Cigna-delegated. Note the SPLIT gates: pain chronicity is
.FACETCIGNA Assessment: *** — facet-mediated chronic axial *** pain from C2-3 to L5-S1, present >=3 months, without untreated radiculopathy (facet synovial cyst with concordant radiculopathy excepted); the index segment has not been previously fused. Medical necessity per Cigna eviCore CMM-201 and CMM-208: pain has been present >=3 months, and >=4 weeks of conservative treatment within the past 3 months — exercise / physical therapy, chiropractic, and NSAIDs — has failed or was contraindicated: *** . Two diagnostic medial branch or intra-articular blocks were performed at the same level(s) *** , each producing >=80% relief of the index pain (*** and ***), within the limit of <=2 diagnostic blocks per level and undertaken with RFA as the intended endpoint. Guidance was fluoroscopic or CT; ultrasound-guided injection is not covered. Plan: Medial branch RF neurotomy using conventional thermal RF at the confirmed level(s) *** (64633/64634 cervical-thoracic; 64635/64636 lumbar-sacral), across <=3 contiguous levels (<=6 if bilateral), within <=2 RFA sessions per level per 12 months and >=6 months apart. [If repeat:] the prior RFA gave >=50% relief lasting >=12 weeks. Risks, benefits, and alternatives discussed; consent obtained.
Where this payor diverges from the Medicare baseline
Cautions
Prior-auth pathway
- required: yes
- pathway: eviCore / Evernorth
Provenance
- authority:
- type: commercial_policy
- id: Cigna eviCore CMM-201 + CMM-208
- title: Facet Joint Injections / MBB (CMM-201) + Ablations/Denervations of Facet Joints (CMM-208)
- delegated by: Cigna (authored by eviCore / Evernorth)
- applies because: Cigna delegates facet diagnostics (CMM-201) and RFA (CMM-208) to eviCore
- source: https://www.evicore.com/sites/default/files/clinical-guidelines/2026-02/Cigna_Facet%20Joint%20Inj_MBB_Final%20(CMM-201)_V1.1.2025_Eff02.25.2026_pub01.30.2026_upd02.13.2026.pdf
- archived copy:
sources/evicore_cmm201-facet-blocks_2026-02-25.pdf(sha256 227570bbfa37… — kept in the content repo, not served here) - effective: 2026-02-25 · payor last reviewed: 2026-02-25 · we verified: 2026-07-24 · v2
Change history
- 2026-07-24commercial cells: re-verify 27 source PDFs by SHA-256 (Carelon/eviCore/UHC/Cigna) - all unchanged vs committed archive; last_verified -> 2026-07-24
3615c231f0 - 2026-07-23facet-joint/cigna v2: min_duration_months encoded chronicity, not the conservative floor
eab5c027b3 - 2026-06-30Archive commercial source PDFs into sources/ + wire source_file/source_hash
c5466694c8 - 2026-06-28Add commercial Facet Joint cells: Anthem(Carelon), UHC, Cigna(eviCore)
962ec9816b